Trends in <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) Bacteremia during the COVID-19 Pandemic: A Systematic Review

<i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) is among the most common pathogens associated with healthcare-acquired infections, and is often antibiotic resistant, causing significant morbidity and mortality in cases of <i>P. aeruginosa</i> bacteremia. It r...

Full description

Bibliographic Details
Main Authors: Qin Xiang Ng, Natasha Yixuan Ong, Dawn Yi Xin Lee, Chun En Yau, Yu Liang Lim, Andrea Lay Hoon Kwa, Ban Hock Tan
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/12/2/409
_version_ 1797622734347304960
author Qin Xiang Ng
Natasha Yixuan Ong
Dawn Yi Xin Lee
Chun En Yau
Yu Liang Lim
Andrea Lay Hoon Kwa
Ban Hock Tan
author_facet Qin Xiang Ng
Natasha Yixuan Ong
Dawn Yi Xin Lee
Chun En Yau
Yu Liang Lim
Andrea Lay Hoon Kwa
Ban Hock Tan
author_sort Qin Xiang Ng
collection DOAJ
description <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) is among the most common pathogens associated with healthcare-acquired infections, and is often antibiotic resistant, causing significant morbidity and mortality in cases of <i>P. aeruginosa</i> bacteremia. It remains unclear how the incidence of <i>P. aeruginosa</i> bacteremia changed during the Coronavirus Disease 2019 (COVID-19) pandemic, with studies showing almost contradictory conclusions despite enhanced infection control practices during the pandemic. This systematic review sought to examine published reports with incidence rates for <i>P. aeruginosa</i> bacteremia during (defined as from March 2020 onwards) and prior to the COVID-19 pandemic. A systematic literature search was conducted in accordance with PRISMA guidelines and performed in Cochrane, Embase, and Medline with combinations of the key words (pseudomonas aeruginosa OR PAE) AND (incidence OR surveillance), from database inception until 1 December 2022. Based on the pre-defined inclusion criteria, a total of eight studies were eligible for review. Prior to the pandemic, the prevalence of <i>P. aeruginosa</i> was on an uptrend. Several international reports found a slight increase in the incidence of <i>P. aeruginosa</i> bacteremia during the COVID-19 pandemic. These findings collectively highlight the continued importance of good infection prevention and control and antimicrobial stewardship during both pandemic and non-pandemic periods. It is important to implement effective infection prevention and control measures, including ensuring hand hygiene, stepping up environmental cleaning and disinfection efforts, and developing timely guidelines on the appropriate prescription of antibiotics.
first_indexed 2024-03-11T09:15:26Z
format Article
id doaj.art-dbd0b26cbf914f5a90c2566c01a64b14
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-11T09:15:26Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-dbd0b26cbf914f5a90c2566c01a64b142023-11-16T18:44:40ZengMDPI AGAntibiotics2079-63822023-02-0112240910.3390/antibiotics12020409Trends in <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) Bacteremia during the COVID-19 Pandemic: A Systematic ReviewQin Xiang Ng0Natasha Yixuan Ong1Dawn Yi Xin Lee2Chun En Yau3Yu Liang Lim4Andrea Lay Hoon Kwa5Ban Hock Tan6Health Services Research Unit, Singapore General Hospital, Singapore 169608, SingaporeYong Loo Lin School of Medicine, National University of Singapore, 10 Medical Dr, Singapore 117597, SingaporeSchool of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow G12 8QQ, UKYong Loo Lin School of Medicine, National University of Singapore, 10 Medical Dr, Singapore 117597, SingaporeMOH Holdings Pte Ltd., 1 Maritime Square, Singapore 099253, SingaporeDepartment of Pharmacy, Singapore General Hospital, Singapore 169608, SingaporeDepartment of Infectious Diseases, Singapore General Hospital, Singapore 169608, Singapore<i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) is among the most common pathogens associated with healthcare-acquired infections, and is often antibiotic resistant, causing significant morbidity and mortality in cases of <i>P. aeruginosa</i> bacteremia. It remains unclear how the incidence of <i>P. aeruginosa</i> bacteremia changed during the Coronavirus Disease 2019 (COVID-19) pandemic, with studies showing almost contradictory conclusions despite enhanced infection control practices during the pandemic. This systematic review sought to examine published reports with incidence rates for <i>P. aeruginosa</i> bacteremia during (defined as from March 2020 onwards) and prior to the COVID-19 pandemic. A systematic literature search was conducted in accordance with PRISMA guidelines and performed in Cochrane, Embase, and Medline with combinations of the key words (pseudomonas aeruginosa OR PAE) AND (incidence OR surveillance), from database inception until 1 December 2022. Based on the pre-defined inclusion criteria, a total of eight studies were eligible for review. Prior to the pandemic, the prevalence of <i>P. aeruginosa</i> was on an uptrend. Several international reports found a slight increase in the incidence of <i>P. aeruginosa</i> bacteremia during the COVID-19 pandemic. These findings collectively highlight the continued importance of good infection prevention and control and antimicrobial stewardship during both pandemic and non-pandemic periods. It is important to implement effective infection prevention and control measures, including ensuring hand hygiene, stepping up environmental cleaning and disinfection efforts, and developing timely guidelines on the appropriate prescription of antibiotics.https://www.mdpi.com/2079-6382/12/2/409<i>P. aeruginosa</i>COVID-19collateral effectantibioticsantimicrobial stewardship
spellingShingle Qin Xiang Ng
Natasha Yixuan Ong
Dawn Yi Xin Lee
Chun En Yau
Yu Liang Lim
Andrea Lay Hoon Kwa
Ban Hock Tan
Trends in <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) Bacteremia during the COVID-19 Pandemic: A Systematic Review
Antibiotics
<i>P. aeruginosa</i>
COVID-19
collateral effect
antibiotics
antimicrobial stewardship
title Trends in <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) Bacteremia during the COVID-19 Pandemic: A Systematic Review
title_full Trends in <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) Bacteremia during the COVID-19 Pandemic: A Systematic Review
title_fullStr Trends in <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) Bacteremia during the COVID-19 Pandemic: A Systematic Review
title_full_unstemmed Trends in <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) Bacteremia during the COVID-19 Pandemic: A Systematic Review
title_short Trends in <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) Bacteremia during the COVID-19 Pandemic: A Systematic Review
title_sort trends in i pseudomonas aeruginosa i i p aeruginosa i bacteremia during the covid 19 pandemic a systematic review
topic <i>P. aeruginosa</i>
COVID-19
collateral effect
antibiotics
antimicrobial stewardship
url https://www.mdpi.com/2079-6382/12/2/409
work_keys_str_mv AT qinxiangng trendsinipseudomonasaeruginosaiipaeruginosaibacteremiaduringthecovid19pandemicasystematicreview
AT natashayixuanong trendsinipseudomonasaeruginosaiipaeruginosaibacteremiaduringthecovid19pandemicasystematicreview
AT dawnyixinlee trendsinipseudomonasaeruginosaiipaeruginosaibacteremiaduringthecovid19pandemicasystematicreview
AT chunenyau trendsinipseudomonasaeruginosaiipaeruginosaibacteremiaduringthecovid19pandemicasystematicreview
AT yulianglim trendsinipseudomonasaeruginosaiipaeruginosaibacteremiaduringthecovid19pandemicasystematicreview
AT andrealayhoonkwa trendsinipseudomonasaeruginosaiipaeruginosaibacteremiaduringthecovid19pandemicasystematicreview
AT banhocktan trendsinipseudomonasaeruginosaiipaeruginosaibacteremiaduringthecovid19pandemicasystematicreview